In addition to IR and -cell dysfunction, obesity in T1DM is concomitantly associated with chronic inflammation, central adiposity and dyslipidemia [18]
In a 68- and 72-week clinical trial studying Wegovy (2.4 mg), brand-name Semaglutide, and Zepbound (15 mg), brand-name Tirzepatide, in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
2021 NEJM) data on 14.9% weight loss assumes properly stored, intact medication FAQ Can I Freeze Compounded Semaglutide
A.WoodmanP
They will assess your medical history before prescribing the medication.
Two of the most talked-about are Ozempic and Wegovy, made by Novo Nordisk